Exchange: NASDAQ·Updated 12:04 PM EDT
NBIX logo

NBIX Neurocrine Biosciences, Inc.

$158.70
$0.91
(0.58%)
Today
EarningsOct 28
Mkt Cap$16.04B
Vol191,851.00

About NBIX

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
48

Neutral Sentiment

How do you feel about NBIX?

Advertisement|Remove ads.